NIH Taps Booz Allen to Support Research Needs of National Cancer Institute

Booz Allen Hamilton has secured a $29.9 million task order that calls for research support services for the National Cancer Institute Center for Biomedical Informatics and Information Technology.

Work under the task will help enhance NCI’s Clinical Trials Reporting Program as the go-to information source for cancer-related clinical trials, facilitate data access across the cancer research ecosystem and support scientific research for the development and deployment of safe and effective COVID-19 vaccines, Booz Allen said Tuesday.

The company aims to support NCI’s needs by providing software development, system engineering and operational support, as well as biomedical information technology, informatics, analytical and consultative services.

The new task falls under the National Institutes of Health’s five-year, $350 million Biomedical Information Technology, Software Development and Informatics Support indefinite-delivery/indefinite-quantity contract.

Roman Salasznyk, senior vice president and leader of Booz Allen’s life science practice, said in a statement that the company looks forward to applying life science, cloud computing, advanced analytics and technology modernization capabilities to accelerate cancer research and care.

In addition to being awarded a spot on the BITSDIS IDIQ, the company is also part of the contractor pool for a potential five-year, $148M contract to help the NCI manage and analyze biomedical information.

Together with Deloitte Consulting, Information Management Services, Research Triangle Institute and Westat, Booz Allen was selected to provide data analytics, modeling, acquisition and management, tool development and statistical and bioinformatic analysis in support of NCI.